| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.4 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |